JPH05503092A - ヒルジン突然変異蛋白質及びヒルジンポリアルキレングリコール複合体 - Google Patents
ヒルジン突然変異蛋白質及びヒルジンポリアルキレングリコール複合体Info
- Publication number
- JPH05503092A JPH05503092A JP3501205A JP50120591A JPH05503092A JP H05503092 A JPH05503092 A JP H05503092A JP 3501205 A JP3501205 A JP 3501205A JP 50120591 A JP50120591 A JP 50120591A JP H05503092 A JPH05503092 A JP H05503092A
- Authority
- JP
- Japan
- Prior art keywords
- hirudin
- array
- mutein
- formula
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/855—Proteins from animals other than mammals or birds
- Y10S530/858—Proteins from animals other than mammals or birds insects; venom
Abstract
Description
Claims (15)
- 1.ポリアルキレングリコール又はポリアルキレングリコール誘導体とヒルジン 、脱スルフェートヒルジン又は血液凝固抑制ヒルジン−突然変異タンパク質とか らの式I: [A−(CH2)m−[O−(CH2)n]m−B−]qHir(I)[式中、 Aは、基−OH,−NH2、−NH−CO−R、−O−R又は−O−CO−Rを 表わし、ここでRは、C1〜C4−アルキレン基を表わし、nは、2、3又は4 の数を表わし、mは、50〜500の数を表わし、Bは、直接共有結合又はリン カーを表わし、pは、1、2又は3の数を表わし、かつHirは、リシン−側鎖 のアミノ基を介してA−(CH2)n−(O−(CH2)n)m基に結合してい る一般式:【配列があります】 (ここで、Aは、【配列があります】 を表わし、Bは、Gln又はGluを表わし、Cは、Lys、Arg、Asnを 表わし、Dは、−Lys−Gly−又は【配列があります】を表わし、ここで、 Uは、Ser、Lys又は直接結合を表わし、Vは、Asp、Lys、Asnを 表わし、Xは、Glu、Gln又は直接結合を表わし、Yは、Lys、Arg、 Asnを表わし、Eは、Lys、Arg、Asn、Glnを表わし、Fは、As p、Glnを表わし、Gは、Glu、Proを表わす)のポリペプチドを表わす ]の複合体。
- 2.ポリアルキレングリコールがポリエチレングリコールである、請求項1記載 の複合体。
- 3.ポリエチレングリコールの分子量が4000〜15000Daである、請求 項2記載の複合体。
- 4.ポリマー基1又は2個がヒルジンに結合している、請求項1から3までのい ずれか1項記載の複合体。
- 5.1種以上のアミノ酸が30〜38の位置で交換もしくは欠失している、請求 項1記載のヒルジン突然変異タンパク質。
- 6.30〜38の位置に、1又は2個の付加的リシン基を含有する、請求項5記 載のヒルジン突然変異タンパク質。
- 7.付加的に、47及び/又は36の位置で、リシンがアルギニン又はグルタミ ンに交換されている、請求項6記載のヒルジン突然変異タンパク質。
- 8.式: 【配列があります】 の、請求項5記載のヒルジン突然変異タンパク質。
- 9.式: 【配列があります】 の、請求項5記載のヒルジン突然変異タンパク質。
- 10.式: 【配列があります】 の、請求項5記載のヒルジン突然変異タンパク質。
- 11.式: 【配列があります】 の、請求項5記載のヒルジン突然変異タンパク質。
- 12.式: 【配列があります】 の、請求項5記載のヒルジン突然変異タンパク質。
- 13.疾病を予防するための、請求項5から12までのいずれか1項記載のヒル ジン突然変異タンパク質並びに相当するポリマー複合体。
- 14.表面被覆のための、請求項5から12までのいずれか1項記載のヒルジン 突然変異タンパク質。
- 15.表面被覆のための、請求項1から4までのいずれか1項記載のポリマー複 合体。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3939800.5 | 1989-12-01 | ||
DE3939800 | 1989-12-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05503092A true JPH05503092A (ja) | 1993-05-27 |
JP3187044B2 JP3187044B2 (ja) | 2001-07-11 |
Family
ID=6394620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50120591A Expired - Lifetime JP3187044B2 (ja) | 1989-12-01 | 1990-11-22 | ヒルジン突然変異蛋白質及びヒルジンポリアルキレングリコール複合体 |
Country Status (9)
Country | Link |
---|---|
US (1) | US5663141A (ja) |
EP (1) | EP0502962B1 (ja) |
JP (1) | JP3187044B2 (ja) |
AT (1) | ATE135374T1 (ja) |
BG (1) | BG62068B2 (ja) |
CA (1) | CA2067224C (ja) |
DE (1) | DE59010205D1 (ja) |
ES (1) | ES2084149T3 (ja) |
WO (1) | WO1991008229A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002540899A (ja) * | 1999-04-08 | 2002-12-03 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 体外腎臓置換療法における抗凝血剤としての分子量を増加させたヒルジンの使用 |
JP2003527442A (ja) * | 2000-03-20 | 2003-09-16 | クノル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 血液体外処理における抗凝固剤の使用 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5595732A (en) * | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
DE4117784A1 (de) * | 1991-05-31 | 1992-12-03 | Basf Ag | Herstellung von protein-polyalkylenglykolkonjugaten |
FR2687681B1 (fr) * | 1992-02-20 | 1995-10-13 | Transgene Sa | Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses. |
US5382657A (en) * | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
HUT72926A (en) * | 1993-08-04 | 1996-06-28 | Ciba Geigy Ag | High molecular weight desulphatohirudin |
DE4437502A1 (de) * | 1993-12-02 | 1995-06-08 | Basf Ag | Hirudin-Konjugate aus Hirudin und lipophilen Verbindungen |
DE4404168A1 (de) * | 1994-02-10 | 1995-08-17 | Hoechst Ag | Hirudinderivate und Verfahren zu deren Herstellung |
DE19533817C2 (de) * | 1995-09-13 | 1999-12-09 | Max Planck Gesellschaft | Komplex-gebundene Hemmstoffe aktivierbarer Stoffwechselenzyme als molekulare Marker zur Diagnostik und Therapieüberwachung |
US20040228852A1 (en) * | 1999-04-08 | 2004-11-18 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V | Use of increased molecular-weight hirudin as an anticoagulant in extracorporeal kidney replace therapy |
US6809076B2 (en) * | 2000-03-20 | 2004-10-26 | Abbott Gmbh & Co. Kg | Use of anticoagulant agents in the extracorporeal treatment of blood |
DE10102878A1 (de) * | 2001-01-23 | 2002-08-01 | Haemosys Gmbh | Oligo- oder Polyalkylengekoppelte Thrombininhibitoren |
DE10162521A1 (de) * | 2001-12-19 | 2003-07-17 | Goetz Nowak | Verwendung von molekulargewichtserweiterten Substanzen in der Tumortherapie |
US7939629B2 (en) | 2004-10-19 | 2011-05-10 | Lonza Ag | Method for solid phase peptide synthesis |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE58903988D1 (de) * | 1985-04-11 | 1993-05-13 | Hoechst Ag | Hirudin-derivat. |
JP2514950B2 (ja) * | 1986-03-10 | 1996-07-10 | エフ・ホフマン―ラ ロシユ アーゲー | 化学修飾蛋白質,その製造法および中間体 |
FR2628429B1 (fr) * | 1988-03-08 | 1990-12-28 | Transgene Sa | Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir |
AU614121B2 (en) * | 1988-05-04 | 1991-08-22 | Novartis Ag | Improvements in the production of polypeptides |
DE3819079A1 (de) * | 1988-06-04 | 1989-12-07 | Hoechst Ag | Hirudin-derivate mit verzoegerter wirkung |
CA2000887A1 (en) * | 1988-11-01 | 1990-05-01 | Cecilia S.L. Ku | Thromboresistant materials and methods for making same |
-
1990
- 1990-11-22 US US07/859,453 patent/US5663141A/en not_active Expired - Lifetime
- 1990-11-22 AT AT91900751T patent/ATE135374T1/de not_active IP Right Cessation
- 1990-11-22 WO PCT/EP1990/001998 patent/WO1991008229A1/de active IP Right Grant
- 1990-11-22 CA CA002067224A patent/CA2067224C/en not_active Expired - Lifetime
- 1990-11-22 DE DE59010205T patent/DE59010205D1/de not_active Expired - Lifetime
- 1990-11-22 ES ES91900751T patent/ES2084149T3/es not_active Expired - Lifetime
- 1990-11-22 EP EP91900751A patent/EP0502962B1/de not_active Expired - Lifetime
- 1990-11-22 JP JP50120591A patent/JP3187044B2/ja not_active Expired - Lifetime
-
1994
- 1994-02-28 BG BG98604A patent/BG62068B2/bg unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002540899A (ja) * | 1999-04-08 | 2002-12-03 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 体外腎臓置換療法における抗凝血剤としての分子量を増加させたヒルジンの使用 |
JP2003527442A (ja) * | 2000-03-20 | 2003-09-16 | クノル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 血液体外処理における抗凝固剤の使用 |
Also Published As
Publication number | Publication date |
---|---|
WO1991008229A1 (de) | 1991-06-13 |
BG62068B2 (bg) | 1999-01-29 |
EP0502962A1 (de) | 1992-09-16 |
EP0502962B1 (de) | 1996-03-13 |
DE59010205D1 (de) | 1996-04-18 |
US5663141A (en) | 1997-09-02 |
CA2067224C (en) | 2001-02-13 |
JP3187044B2 (ja) | 2001-07-11 |
CA2067224A1 (en) | 1991-06-02 |
ATE135374T1 (de) | 1996-03-15 |
ES2084149T3 (es) | 1996-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5384309A (en) | Cyclized peptides and their use as platelet aggregation inhibitors | |
US6060451A (en) | Thrombin inhibitors based on the amino acid sequence of hirudin | |
JPH05503092A (ja) | ヒルジン突然変異蛋白質及びヒルジンポリアルキレングリコール複合体 | |
CA2678001C (en) | Therapeutic application of kazal-type serine protease inhibitors | |
JPH07508404A (ja) | ヒト/ブタハイブリッド第viii因子 | |
HU211158A9 (en) | Novel inhibitors of thrombin | |
JPH10513151A (ja) | トロンビン阻害剤としての複素環式ケトアルギニンペプチド | |
JPH04505753A (ja) | 血小板活性化阻害ポリペプチドを製造する方法ならびにそれを用いた方法,組合せおよび組成物 | |
CA2009390A1 (en) | Viper venom polypeptides and variants | |
JPH06502407A (ja) | 血小板凝集阻害剤 | |
JP2000509993A (ja) | アポリポタンパク質b―100由来の抗凝血性ペプチド断片 | |
US5583111A (en) | Thrombin inhibitors | |
JP2669510B2 (ja) | ヒルジンのアミノ酸配列に基づくトロンビン阻害剤 | |
US5229367A (en) | Antiinflammatory peptide derived from human lipocortin V | |
US6117836A (en) | Glycosylation-mediated inhibition of factor X | |
JPH08507200A (ja) | 昆虫類の唾液からのトロンビン阻害剤 | |
NZ508770A (en) | Textilinin plasmin inhibitors from the Australian brown snake pseudonaja textilis textilis | |
JPH08511157A (ja) | Xaファクター阻害活性を有する新規ポリペプチド | |
JPH0315389A (ja) | アンクロッド様ポリペプチドをコードする新規dna配列およびそれらの発現生成物より成る組成物 | |
HU200939B (en) | Process for stabilizing htnf obtained by recombinant dna technique | |
JPH1080281A (ja) | 新規蛋白質及びその製造方法 | |
JPH08510903A (ja) | 蛭ヒルド・メディシナリスの組換えxa因子インヒビターの作製 | |
US20020142372A1 (en) | Fragments of cr1 and their use | |
AU759190B2 (en) | Plasmin inhibitors from the Australian brown snake (Pseudonaja textilis textilis) | |
AU2008214916B2 (en) | Therapeutic application of Kazal-type serine protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090511 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100511 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110511 Year of fee payment: 10 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110511 Year of fee payment: 10 |